Literature DB >> 15016191

HLA class II genetic association of type 1 diabetes mellitus in Czech children.

O Cinek1, S Kolousková, M Snajderová, Z Sumník, P Sedláková, P Drevínek, J Vavrinec, K S Ronningen.   

Abstract

To examine human leukocyte antigen (HLA) class II association of type 1 diabetes mellitus (DM) in Czech children, we performed a case-control study of 261 patients diagnosed before the age of 15 and 289 non-diabetic control children. Complete HLA-DQA1, DQB1 genotyping and DRB1*04 subtyping were carried out by polymerase chain reactions with sequence-specific primers. The effect of the DRB1*04 subtypes was studied in DRB1*04 alleles carried on DQB1*0302-DQA1*03 haplotypes. The risk was statistically evaluated by testing 2 x 2 tables, considering corrected p-values < 0.05 significant. The DQB1*0302 (odds ratio, OR = 9.0), DQB1*0201 (OR = 3.4) and DQA1*03 (OR = 7.5) alleles were significantly associated with diabetes risk, while the DQB1*0602 (OR = 0.02), DQB1*0301 (OR = 0.08), DQB1*0503 (OR = 0.13), DQB1*0603 (OR = 0.20), DQA1*01 (OR = 0.28) and DQA1*02 (OR = 0.26) alleles were significantly protective. Of the DQA1-DQB1 genotypes, we point out the extremely high risk of OR = 116 conferred by HLA-DQA1*05-DQB1*0201/DQA1*03-DQB1*0302. Among DRB1*04 subtypes, DRB1*0403 was significantly protective (OR = 0.05, CI 95% 0.01-0.45). Since none of the remaining DRB1*04 subtypes was associated with type 1 DM, our study may present another piece of evidence that the DRB1*0401 and DRB1*0404 alleles do not modify type 1 diabetes risk generally in European populations.

Entities:  

Year:  2001        PMID: 15016191     DOI: 10.1034/j.1399-5448.2001.002003098.x

Source DB:  PubMed          Journal:  Pediatr Diabetes        ISSN: 1399-543X            Impact factor:   4.866


  8 in total

1.  Age-dependent loss of tolerance to an immunodominant epitope of glutamic acid decarboxylase in diabetic-prone RIP-B7/DR4 mice.

Authors:  John A Gebe; Kellee A Unrath; Ben A Falk; Kouichi Ito; Li Wen; Terri L Daniels; Ake Lernmark; Gerald T Nepom
Journal:  Clin Immunol       Date:  2006-09-18       Impact factor: 3.969

2.  The relation between size at birth and risk of type 1 diabetes is not influenced by adjustment for the insulin gene (-23HphI) polymorphism or HLA-DQ genotype.

Authors:  L C Stene; P M Thorsby; J P Berg; K S Rønningen; D E Undlien; G Joner
Journal:  Diabetologia       Date:  2006-05-12       Impact factor: 10.122

3.  Case report: type 1 diabetes in monozygotic quadruplets.

Authors:  Katerina Stechova; Zbynek Halbhuber; Miluse Hubackova; Jana Kayserova; Lenka Petruzelkova; Jana Vcelakova; Stanislava Kolouskova; Tereza Ulmannova; Maria Faresjö; Ales Neuwirth; Radek Spisek; Anna Sediva; Dominik Filipp; Zdenek Sumnik
Journal:  Eur J Hum Genet       Date:  2011-11-23       Impact factor: 4.246

4.  High prevalence of coeliac disease in siblings of children with type 1 diabetes.

Authors:  Zdenek Sumnik; Stanislava Kolouskova; Hana Malcova; Jan Vavrinec; Jitrenka Venhacova; Jan Lebl; Ondrej Cinek
Journal:  Eur J Pediatr       Date:  2004-10-07       Impact factor: 3.183

5.  HLA-DQB1* alleles and genetic susceptibility to type 1 diabetes mellitus.

Authors:  Youssef M Mosaad; Fatma A Auf; Shereen S Metwally; Ashraf A Elsharkawy; Amany K El-Hawary; Rasha H Hassan; Ziyad E Tawhid; Farha A El-Chennawi
Journal:  World J Diabetes       Date:  2012-08-15

6.  HLA Class II Allele, Haplotype, and Genotype Associations with Type 1 Diabetes in Benin: A Pilot Study.

Authors:  Kaossarath A Fagbemi; Thierry C Marc Medehouenou; Simon Azonbakin; Marius Adjagba; Razack Osseni; Jocelyne Ahoueya; Arnaud Agbanlinsou; Raphael Darboux; Lamine Baba-Moussa; Anatole Laleye
Journal:  J Diabetes Res       Date:  2017-07-20       Impact factor: 4.011

7.  Joint effects of HLA, INS, PTPN22 and CTLA4 genes on the risk of type 1 diabetes.

Authors:  M Bjørnvold; D E Undlien; G Joner; K Dahl-Jørgensen; P R Njølstad; H E Akselsen; K Gervin; K S Rønningen; L C Stene
Journal:  Diabetologia       Date:  2008-02-22       Impact factor: 10.122

8.  Myeloid - derived suppressor cells in Type 1 diabetes are an expanded population exhibiting diverse T-cell suppressor mechanisms.

Authors:  Anna Grohová; Klára Dáňová; Irena Adkins; Zdeněk Šumník; Lenka Petruželková; Barbora Obermannová; Stanislava Koloušková; Radek Špíšek; Lenka Palová-Jelínková
Journal:  PLoS One       Date:  2020-11-18       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.